Axsome Therapeutics Investor Relations Material
Latest events
Q1 2025
Axsome Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Axsome Therapeutics Inc
Access all reports
Axsome Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing therapies for central nervous system (CNS) disorders. The company's portfolio includes product candidates designed to address conditions such as depression, migraines, and other neurological and psychiatric disorders. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Key slides for Axsome Therapeutics Inc
Q4 2024
Axsome Therapeutics Inc
Study Result
Axsome Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AXSM
Country
🇺🇸 United States